Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Looking Beyond Surveillance, Epidemiology, and End Results Patterns of Chemotherapy Administration for Advanced Non-small Cell Lung Cancer in a Contemporary, Diverse Population

Looking Beyond Surveillance, Epidemiology, and End Results Patterns of Chemotherapy... ORIGINAL ARTICLE Looking Beyond Surveillance, Epidemiology, and End Results Patterns of Chemotherapy Administration for Advanced Non-small Cell Lung Cancer in a Contemporary, Diverse Population Drew W. Rasco, MD,* Jingsheng Yan, PhD,† Yang Xie, PhD,† Jonathan E. Dowell, MD,* and David E. Gerber, MD* Key Words: Non small-cell lung cancer, Chemotherapy, Metastatic, Introduction: Chemotherapy prolongs survival without substan- Practice patterns, Insurance. tially impairing quality of life for medically fit patients with ad- (J Thorac Oncol. 2010;5: 1529–1535) vanced non-small cell lung cancer (NSCLC), but population-based studies have shown that only 20 to 30% of these patients receive chemotherapy. These earlier studies have relied on Medicare-linked hemotherapy has a well-defined role in the treatment of Surveillance, Epidemiology, and End Results (SEER) data, thus ex- Cmedically fit patients with advanced non-small cell lung cluding the 30 to 35% of lung cancer patients younger than 65 years. cancer (NSCLC). Compared with best supportive care, che- Therefore, we determined the use of chemotherapy in a contemporary, motherapy prolongs overall survival without substantially diverse NSCLC population encompassing all patient ages. 1–5 impairing quality of life. Nevertheless, population-based Methods: We performed a retrospective analysis of patients diag- studies from the 1990s have shown that only 22 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Looking Beyond Surveillance, Epidemiology, and End Results Patterns of Chemotherapy Administration for Advanced Non-small Cell Lung Cancer in a Contemporary, Diverse Population

Gerber, David E.
Journal of Thoracic Oncology , Volume 5 (10) – Oct 1, 2010
Download PDF
7 pages

Loading next page...
 
/lp/wolters-kluwer-health/looking-beyond-surveillance-epidemiology-and-end-results-patterns-of-raNXQdKYLZ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864
DOI
10.1097/JTO.0b013e3181e9a00f
pmid
20631635
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Looking Beyond Surveillance, Epidemiology, and End Results Patterns of Chemotherapy Administration for Advanced Non-small Cell Lung Cancer in a Contemporary, Diverse Population Drew W. Rasco, MD,* Jingsheng Yan, PhD,† Yang Xie, PhD,† Jonathan E. Dowell, MD,* and David E. Gerber, MD* Key Words: Non small-cell lung cancer, Chemotherapy, Metastatic, Introduction: Chemotherapy prolongs survival without substan- Practice patterns, Insurance. tially impairing quality of life for medically fit patients with ad- (J Thorac Oncol. 2010;5: 1529–1535) vanced non-small cell lung cancer (NSCLC), but population-based studies have shown that only 20 to 30% of these patients receive chemotherapy. These earlier studies have relied on Medicare-linked hemotherapy has a well-defined role in the treatment of Surveillance, Epidemiology, and End Results (SEER) data, thus ex- Cmedically fit patients with advanced non-small cell lung cluding the 30 to 35% of lung cancer patients younger than 65 years. cancer (NSCLC). Compared with best supportive care, che- Therefore, we determined the use of chemotherapy in a contemporary, motherapy prolongs overall survival without substantially diverse NSCLC population encompassing all patient ages. 1–5 impairing quality of life. Nevertheless, population-based Methods: We performed a retrospective analysis of patients diag- studies from the 1990s have shown that only 22

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Oct 1, 2010

References

  • Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer
    Cartei
  • Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study
    Quoix
  • Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life
    Spiro
  • Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group
  • Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials
  • Impact of referral patterns on the use of chemotherapy for lung cancer
    Earle
  • Who gets chemotherapy for metastatic lung cancer?
    Earle
  • Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare
    Ramsey
  • Differences in primary care clinicians' approach to non-small cell lung cancer patients compared with breast cancer
    Wassenaar